The $1bn fine paid for interbank lending manipulation it failed to prevent in its investment banking arm has shaken the foundations of the Dutch lender
Shares gained 2% after Sanofi revised down its full-year net income target. The market, it seems, believes the French pharma group has enough in its product pipeline